Latest News for: emcure

Edit

Emcure pushes into obesity segment with Poviztra, priced at ₹2,200 weekly

Live Mint 22 Dec 2025
Despite an impending patent cliff in 2026 that will invite generic competition from companies like Sun Pharma and Dr. Reddy's, Emcure’s leadership believes the ‘innovator edge’ and a robust metabolic portfolio will secure long-term market dominance.
Edit

Emcure Pharma launches second Novo drug for weight management

The Economic Times 22 Dec 2025
Emcure Pharmaceuticals has taken a bold step in the realm of health and wellness ...
Edit

Stocks To Watch: RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, And Others

News18 18 Nov 2025
Stocks to watch. Shares of firms like RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, and others will be in focus on Tuesday's�trade ....
Edit

Emcure Pharma Block Deal: Bain Capital To Offload Shares Worth Nearly Rs 500 Crore

NDTV 17 Nov 2025
Bain Capital held a 6.3% stake as of September, currently valued at Rs 1,660 crore ... .
Edit

Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India

NDTV 10 Nov 2025
As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra in India ... .
×